½ÃÀ庸°í¼­
»óǰÄÚµå
1804705

°íÁ¤Çü C-arm ½ÃÀå : Á¦Ç° À¯Çü, ±â¼ú, °ËÃâ±â À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Fixed C-arm Market by Product Type, Technology, Detector Type, Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°íÁ¤Çü C-arm ½ÃÀåÀº 2024³â¿¡ 12¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2025³â¿¡´Â 14¾ï 1,000¸¸ ´Þ·¯¿¡ À̸£°í, CAGR 9.24%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 22¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ : 2024³â 12¾ï 9,000¸¸ ´Þ·¯
ÃßÁ¤ ¿¬µµ : 2025³â 14¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ : 2030³â 22¾ï ´Þ·¯
CAGR(%) 9.24%

Çö´ë ÀÇ·á ¿µ»ó Áø´Ü¿¡¼­ °íÁ¤½Ä C-armÀÇ ÁøÈ­: Àü ¼¼°è ÀÓ»ó ÇöÀåÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» À§ÇÑ »õ·Î¿î ÀÌÁ¤Ç¥ ¸¶·Ã

°íÁ¤½Ä C-arm ½Ã½ºÅÛÀº ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼­ ÇʼöÀûÀÎ ÀÚ»êÀÌ µÇ¾î ½Ã¼úÀÇ Á¤È®¼º°ú ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½ÃŰ´Â ½Ç½Ã°£ Åõ½Ã °¡À̵带 Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µ»ó Ç÷§ÆûÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, ÀÓ»óÀû ¿µÇâ°ú ±â¼úÀû Áøº¸¸¦ ÀÌÇØÇÏ´Â °ÍÀº Áø·á °æ·Î¸¦ ÃÖÀûÈ­ÇϰíÀÚ ÇÏ´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­´Â Ãʱ⠾Ƴ¯·Î±× ½Ã½ºÅÛ¿¡¼­ ¿À´Ã³¯ÀÇ Ã·´Ü µðÁöÅÐ ¹× 3Â÷¿ø ¿µ»ó ¼Ö·ç¼Ç¿¡ À̸£±â±îÁö °íÁ¤½Ä C-armÀÇ ¹ßÀü °úÁ¤À» ÃßÀûÇϸ鼭, °íÁ¤½Ä C-arm¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.

Çõ½ÅÀûÀÎ ¿µ»ó ¼Ö·ç¼ÇÀ» Çü¼ºÇÏ´Â ±â¼úÀû À¶ÇÕ°ú ÀÓ»óÀû ÃßÁø·ÂÀ» ÅëÇØ °íÁ¤½Ä C-armÀÇ Á¤¼¼¸¦ ¹Ù²Ù´Â º¯È­¸¦ ¹àÈü´Ï´Ù.

°íÁ¤½Ä C-arm ½ÃÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¼ö·Å°ú ÀÓ»óÀû ¿ä±¸ÀÇ º¯È­·Î ÀÎÇØ Å« º¯È­ÀÇ ½Ã±â¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. 2Â÷¿ø Åõ½Ã¿¡¼­ 3Â÷¿ø ¿µ»óÀ¸·ÎÀÇ ÀüȯÀº ¼ö¼ú °èȹ°ú ¼ö¼ú Áß Å½»öÀ» ÀçÁ¤ÀÇÇÏ¿© °ú°Å¿¡´Â ½Ç¿ëÀûÀÌÁö ¾Ê¾Ò´ø º¹ÀâÇÑ °³ÀÔÀ» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ÀΰøÁö´É, À̹ÌÁö À¶ÇÕ, ½Ç½Ã°£ ºÐ¼®¿¡ À̸£´Â ÷´Ü ¼ÒÇÁÆ®¿þ¾î Á¦Ç°±ºÀÌ ÅëÇÕµÇ¾î °¢ ¿µ»ó Áø´Ü ¼¼¼ÇÀÇ À¯¿ë¼ºÀ» ³ôÀ̰í ÀÓ»óÀÇ¿¡°Ô ȯÀÚ °á°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ´Â ¿ªµ¿ÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

2025³â ¹Ì±¹ °ü¼¼°¡ °íÁ¤½Ä C-arm °ø±Þ¸Á°ú ½ÃÀå °æÀï ¿ªÇп¡ ¹ÌÄ¡´Â ´©Àû ¿µÇâ Æò°¡

2025³â, ¹Ì±¹Àº °íÁ¤½Ä C-¾Ï Á¦Á¶ ¹× À¯Åë¿¡ ÇʼöÀûÀÎ ÁÖ¿ä ºÎǰ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÏ·ÃÀÇ °ü¼¼ Á¶Ä¡¸¦ ½ÃÇàÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °ü¼¼ Á¶Ä¡·Î ÀÎÇØ °ø±Þ¸Á °¢ ´Ü°è¿¡ »õ·Î¿î ºñ¿ë º¯µ¿ ¿äÀÎÀÌ µµÀԵǾî Á¦Á¶¾÷ü, À¯Åë¾÷ü, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â Á¶´Þ Àü·«À» Àç°ËÅäÇØ¾ß ÇÕ´Ï´Ù. ÆòÆÇ °ËÃâ±â, À̹ÌÁö ÀÎÅÙ½ÃÆÄÀ̾î, Ư¼ö ¿¢½º·¹ÀÌ Æ©ºê °ø±Þ¾÷ü´Â ÇöÀç °ü¼¼ ÀÎ»ó¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÃÖÁ¾ »ç¿ëÀÚ ÀåºñÀÇ °¡°Ý »ó½Â ¾Ð·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

±â¼ú ÃÖÁ¾ »ç¿ëÀÚ Á¦Ç° À¯Çü ¹× ÀÓ»ó ÀÀ¿ë ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ °íÁ¤½Ä C-arm ½ÃÀå ¼¼ºÐÈ­¸¦ ÅëÇØ Àü·«Àû ÀλçÀÌÆ®À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹Ì¹¦ÇÑ ¼¼ºÐÈ­ ºÐ¼®À» ÅëÇØ ±â¼ú °èÃþ, ÃÖÁ¾ »ç¿ëÀÚ È¯°æ, Á¦Ç° À¯Çü ¹× ¿ëµµ ¿µ¿ª¿¡ °ÉÄ£ ¸íÈ®ÇÑ Ã¤Åà ÆÐÅÏÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ã½ºÅÛÀ» 2Â÷¿ø°ú 3Â÷¿ø ¸ð´Þ¸®Æ¼·Î ºÐ·ùÇÔÀ¸·Î½á ÀÌÇØ°ü°èÀÚµéÀº ÅõÀÚ ¹æÇâÀ» ÆÄ¾ÇÇÏ°í °í±Þ ¿µ»ó ó¸® Á¦Ç°±ºÀÇ ¼º¼÷ °î¼±À» ¿¹ÃøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)ºÎÅÍ Áø´Ü¼¾ÅÍ, º´¿ø, Àü¹® Ŭ¸®´Ð¿¡ À̸£±â±îÁö ÃÖÁ¾ »ç¿ëÀÚ´Â ¼Õ±â¼ú, ÀÓ»ó Àü¹®¼º, °ø°£ Á¦¾à µîÀÇ ¿µÇâÀ» ¹Þ¾Æ ´Ù¾çÇÑ ±¸¸Å ±âÁØÀ» Á¦½ÃÇÕ´Ï´Ù.

¹ÌÁÖ, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °íÁ¤½Ä C-arm º¸±ÞÀ» ÃËÁøÇÏ´Â Áö¿ª ¿ªÇÐ ½ÃÀå µ¿Çâ°ú ÀÓ»ó ¼ö¿ä

Áö¿ªÀû ¿ªÇÐÀº °íÁ¤½Ä C-arm ¿µ¿ª ¼ö¿ä ÆÐÅϰú Àü·«Àû ¿ì¼±¼øÀ§ ¸ðµÎ¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ºÏ¹Ì¿Í ³²¹Ì¿¡¼­´Â ³ëÈÄÈ­µÈ ÀÇ·á±â±âÀÇ ±³Ã¼¿Í ÃÖ¼Òħ½ÀÀû ½ÉÀå ¼ö¼ú ¹× Á¤Çü¿Ü°ú ¼ö¼úÀ» Áö¿øÇϱâ À§ÇÑ 3Â÷¿ø ¿µ»ó µµÀÔÀÌ ±âÁ¸ ÀÇ·á ½Ã½ºÅÛÀÇ ¿ì¼±¼øÀ§°¡ µÇ°í ÀÖ½À´Ï´Ù. ¿¹»ê ÁÖ±â¿Í »óȯ Àμ¾Æ¼ºê´Â Á¶´ÞÀ» ´õ¿í ÃËÁøÇϰí, ±¹³» Á¦Á¶ ´É·ÂÀº °ü¼¼ º¯µ¿¿¡ ´ëÇÑ ³»¼ºÀ» Á¦°øÇÕ´Ï´Ù.

È¿°úÀûÀÎ Àü·«À» °¡Áø ÁÖ¿ä °íÁ¤½Ä C-arm º¥´õ ÇÁ·ÎÆÄÀϸµ ¿ªµ¿ÀûÀÎ ÇコÄɾî ȯ°æ¿¡¼­ Àü·«Àû ÆÄÆ®³Ê½Ê°ú °æÀïÀû Â÷º°È­¸¦ ÅëÇØ ½ÃÀåÀ» Çü¼ºÇÕ´Ï´Ù.

°íÁ¤½Ä C-arm ºÐ¾ßÀÇ ÁÖ¿ä ¾÷üµéÀº Çõ½ÅÀûÀÎ Çϵå¿þ¾î ¼³°è, ¼ÒÇÁÆ®¿þ¾î Áß½ÉÀÇ ±â´É, Á¾ÇÕÀûÀÎ ¼­ºñ½º Á¦°øÀÇ Á¶ÇÕÀ» ÅëÇØ Â÷º°È­¸¦ ²ÒÇϰí ÀÖ½À´Ï´Ù. ÀϺΠ°ø±Þ¾÷ü´Â ¸ðµâ½Ä ¾÷±×·¹À̵å ŰƮ¸¦ µµÀÔÇÏ¿© ½Ã½ºÅÛÀ» ¿ÏÀüÈ÷ ±³Ã¼ÇÏÁö ¾Ê°íµµ 2Â÷¿ø À̹ÌÁö¿¡¼­ 3Â÷¿ø À̹ÌÁö·Î ÀüȯÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ¼³ºñ ÅõÀÚ¸¦ º¸È£Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ» Ȱ¿ëÇÏ¿© ¿ø°Ý ¸ð´ÏÅ͸µ, ¿¹Áöº¸Àü °æº¸, ¼ÒÇÁÆ®¿þ¾î ¾÷µ¥ÀÌÆ®¸¦ ÅëÇØ ´Ù¿îŸÀÓÀ» È¿°úÀûÀ¸·Î ÁÙÀ̰í ÀÚ»ê Ȱ¿ëÀ» ÃÖÀûÈ­ÇÏ´Â ±â¾÷µµ ÀÖ½À´Ï´Ù.

°íÁ¤½Ä C-armÀÇ Çõ½ÅÀ» °¡¼ÓÈ­Çϰí, ¾÷¹« È¿À²¼ºÀ» ³ôÀ̰í, Áö¼Ó °¡´ÉÇÑ ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ ¾÷°è ¸®´õ¿¡°Ô ½ÇÇà °¡´ÉÇÑ Á¦¾ÈÀ» Á¦°øÇÕ´Ï´Ù.

¾÷°è ¸®´õ´Â ¹æ»ç¼± ÇÇÆøÀ» ÁÙÀÌ°í ½Ã¼úÀÇ Á¤È®µµ¸¦ ³ôÀÌ´Â 3Â÷¿ø ¿µ»ó ó¸® ±â´ÉÀÇ ¿¬±¸°³¹ßÀ» ¿ì¼±¼øÀ§·Î »ï¾Æ¾ß ÇÕ´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¿µ»ó ºÐ¼®¿¡ ´ëÇÑ ÅõÀÚ´Â Áø´ÜÀÇ ½Å·Ú¼ºÀ» ´õ¿í ³ôÀ̰í, ½Ç½Ã°£ ÀÇ»ç°áÁ¤À» Áö¿øÇÕ´Ï´Ù. ÀÌ¿Í ÇÔ²², IT ¹× ·Îº¿ ¼ö¼ú Á¦°ø¾÷ü¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÔÀ¸·Î½á Àúħ½À Ä¡·á¸¦ Áß½ÉÀ¸·Î ÁøÈ­ÇÏ´Â Ä¡·á ¸ðµ¨¿¡ µû¸¥ ÅëÇÕ ¼Ö·ç¼ÇÀ» âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù.

µ¥ÀÌÅÍ ¼öÁý °ËÁõ ¹× ºÐ¼® ÇÁ·¹ÀÓ¿öÅ© µî °íÁ¤½Ä C-arm ½ÃÀå ºÐ¼®À» µÞ¹ÞħÇÏ´Â ¾ö°ÝÇÑ Á¶»ç ¹æ¹ý·Ð¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ³»¿ë

º» ºÐ¼®Àº ÅëÂû·ÂÀÇ Æø°ú ±íÀ̸¦ ¸ðµÎ È®º¸Çϱâ À§ÇØ °í¾ÈµÈ ¾ö°ÝÇÑ ´Ù´Ü°è Á¶»ç ¹æ¹ýÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â ÀÎÅͺ¥¼Ç ¿µ»óÀÇÇаú Àü¹®ÀÇ, Á¤Çü¿Ü°ú ÀÇ»ç, ¿µ»ó ±â¼úÀÚ, Á¶´Þ ´ã´ç ÀÓ¿ø µî KOL(Key Opinion Leader)¸¦ ´ë»óÀ¸·Î ½ÉÃþ ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ´ëÈ­¸¦ ÅëÇØ ÀÓ»óÀû ¿ä±¸, ±â¼ú äÅà ÃËÁø¿äÀÎ, Á¶´Þ ÀÇ»ç°áÁ¤ °úÁ¤¿¡ ´ëÇÑ ÁúÀû °üÁ¡À» ¾òÀ» ¼ö ÀÖ¾ú½À´Ï´Ù.

ÁÖ¿ä ¿¬±¸ °á°ú¿Í Àü·«Àû ÀλçÀÌÆ®À» ÅëÇÕÇÏ¿© ÇコÄÉ¾î ½Ã½ºÅÛ¿¡¼­ °íÁ¤½Ä C-arm äÅÃÀÇ Çõ½Å°ú °¡Ä¡ Á¦°øÀÇ ¹Ì·¡ ±ËÀûÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀλçÀÌÆ® Á¦°ø

ÀÌ ÁÖ¿ä ¿ä¾àÀ» ÅëÇØ °íÁ¤½Ä C-arm ±â¼úÀÇ ±ËÀûÀ» Çü¼ºÇÏ´Â Áß¿äÇÑ ÁöÇüÀ» °¡·ÎÁú·¯ ¿Ô½À´Ï´Ù. ±âÃÊÀûÀÎ ¼Ò°³ºÎÅÍ ÀÓ»ó ¹× ±ÔÁ¦ ȯ°æÀÇ °Ýº¯±îÁö, °¢ ¼½¼ÇÀº ÷´Ü ¿µ»ó Áø´Ü ¾ç½ÄÀÌ ¾î¶»°Ô ȯÀÚ Ä¡·á¸¦ ÀçÁ¤ÀÇÇϰí ÀÖ´ÂÁö¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀÌÇØ¿¡ ±â¿©Çß½À´Ï´Ù. °ü¼¼ÀÇ ¿ªÇÐ, ¼¼ºÐÈ­ÀÇ ´µ¾Ó½º, Áö¿ªÀû Â÷ÀÌ, °ø±Þ¾÷ü Àü·«ÀÇ »óÈ£ ÀÛ¿ëÀº ÀÌ ½ÃÀåÀÇ ´Ù¸éÀûÀÎ ¼º°ÝÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ¿ªÇÐ

Á¦6Àå ½ÃÀå ÀλçÀÌÆ®

  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦7Àå ¹Ì±¹ °ü¼¼ÀÇ ´©Àû ¿µÇâ 2025

Á¦8Àå °íÁ¤Çü C-arm ½ÃÀå : Á¦Ç° À¯Çüº°

  • Angiographic C-arms
  • Ceiling-Mounted C-arms
  • Floor-Mounted C-arms

Á¦9Àå °íÁ¤Çü C-arm ½ÃÀå : ±â¼úº°

  • ¾Æ³¯·Î±× C-arm
  • µðÁöÅÐ C-arm

Á¦10Àå °íÁ¤Çü C-arm ½ÃÀå : °ËÃâ±â À¯Çüº°

  • Ç÷§ ÆÐ³Î °ËÃâ±â
  • À̹ÌÁö ÀÎÅÙ½ÃÆÄÀ̾î

Á¦11Àå °íÁ¤Çü C-arm ½ÃÀå : ¿ëµµº°

  • ½ÉÀåÇ÷°ü ¿µ»ó Áø´Ü
  • ¼ÒÈ­±â³»°ú
  • Á¾¾çÇÐ
  • Á¤Çü¿Ü°ú
  • ºñ´¢±â°ú

Á¦12Àå °íÁ¤Çü C-arm ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦13Àå ¾Æ¸Þ¸®Ä«ÀÇ °íÁ¤Çü C-arm ½ÃÀå

  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª

Á¦14Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °íÁ¤Çü C-arm ½ÃÀå

  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ·¯½Ã¾Æ
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • µ§¸¶Å©
  • ³×´ú¶õµå
  • īŸ¸£
  • Çɶõµå
  • ½º¿þµ§
  • ³ªÀÌÁö¸®¾Æ
  • ÀÌÁýÆ®
  • Æ¢¸£Å°¿¹
  • À̽º¶ó¿¤
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • ½ºÀ§½º

Á¦15Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °íÁ¤Çü C-arm ½ÃÀå

  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • Àεµ³×½Ã¾Æ
  • ű¹
  • Çʸ®ÇÉ
  • ¸»·¹À̽þÆ
  • ½Ì°¡Æ÷¸£
  • º£Æ®³²
  • ´ë¸¸

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2024
  • °æÀï ºÐ¼®
    • BMI Biomedical International s.r.l.
    • Canon Medical Systems Corporation
    • Eurocolumbus srl.
    • FUJIFILM Corporation
    • GE HealthCare Technologies Inc
    • Genoray Co., Ltd
    • Hologic, Inc.
    • Koninklijke Philips N.V
    • MIZAR HEALTH, S.L
    • MS Westfalia GmbH
    • Nanjing Perlove Medical Equipment Co., Ltd.
    • Shimadzu Corporation
    • Siemens Healthineers
    • Villa Sistemi Medicali Spa.
    • Ziehm Imaging GmbH

Á¦17Àå ¸®¼­Ä¡ AI

Á¦18Àå ¸®¼­Ä¡ Åë°è

Á¦19Àå ¸®¼­Ä¡ ÄÁÅÃÆ®

Á¦20Àå ¸®¼­Ä¡ ±â»ç

Á¦21Àå ºÎ·Ï

LSH

The Fixed C-arm Market was valued at USD 1.29 billion in 2024 and is projected to grow to USD 1.41 billion in 2025, with a CAGR of 9.24%, reaching USD 2.20 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.29 billion
Estimated Year [2025] USD 1.41 billion
Forecast Year [2030] USD 2.20 billion
CAGR (%) 9.24%

Setting the Stage for Fixed C-arm Evolution in Modern Medical Imaging: Pioneering Efficiency and Precision Across Clinical Environments Worldwide

Fixed C-arm systems have become indispensable assets within a wide array of clinical settings, offering real-time fluoroscopic guidance that enhances procedural accuracy and patient safety. As these imaging platforms continue to evolve, understanding their clinical impact and technological advancements is critical for providers aiming to optimize care pathways. This report delivers a thorough overview of fixed C-arm developments, tracing the journey from early analog systems to today's advanced digital and three-dimensional imaging solutions.

In recent years, the integration of high-resolution detectors and sophisticated image processing algorithms has elevated the diagnostic and interventional capabilities of fixed C-arms. Healthcare institutions can now rely on consistent image quality, minimal distortion, and superior contrast resolution, which in turn supports more precise decision-making in complex procedures. Moreover, the ergonomic design enhancements found in modern installations facilitate seamless workflow, reduce procedure times, and improve operator comfort.

Furthermore, fixed C-arm adoption extends beyond major hospital environments into ambulatory surgical centers, diagnostic centers, and specialty clinics. Each setting imposes unique requirements regarding space utilization, procedural volume, and the range of applications. This introduction lays the foundation for a detailed examination of the market drivers, technological milestones, and clinical imperatives that shape the ongoing adoption of fixed C-arm platforms.

Looking ahead, this executive summary will explore transformative shifts in the landscape, assess emerging regulatory impacts, delineate key segmentation and regional insights, and culminate in actionable recommendations enabled by rigorous research methodologies. By the end of this analysis, decision-makers will possess a clear understanding of the fixed C-arm terrain and be well-equipped to navigate its future trajectory.

Unveiling the Shifts Redrawing the Fixed C-arm Landscape Through Technological Convergence and Clinical Drivers Shaping Innovative Imaging Solutions

The fixed C-arm market is undergoing profound transformation driven by rapid technological convergence and shifting clinical imperatives. The transition from two-dimensional fluoroscopy to three-dimensional imaging has redefined procedural planning and intraoperative navigation, enabling complex interventions that were once impractical. In parallel, the integration of advanced software suites-spanning artificial intelligence, image fusion, and real-time analytics-has elevated the utility of each imaging session, offering clinicians dynamic insights that bolster patient outcomes.

Moreover, regulatory bodies and reimbursement frameworks have begun to acknowledge the value proposition of higher-end imaging modalities. As a result, capital investment cycles are being recalibrated to accommodate next-generation systems that promise not only superior image fidelity but also enhanced data interoperability with electronic health records and surgical navigation platforms. This interoperability is critical for creating unified care pathways, reducing redundant imaging studies and increasing throughput without compromising safety.

In addition, market participants are forging strategic partnerships with IT providers, robotics firms, and specialist device manufacturers to deliver turnkey solutions that align with evolving care models. These alliances underscore the expanding role of fixed C-arms as component parts of broader procedure rooms designed for minimally invasive therapies. Consequently, end users are demanding more flexible installation footprints, modular upgrade paths, and predictive maintenance capabilities fueled by internet-of-things connectivity.

As convergence accelerates, industry stakeholders must remain vigilant to emerging clinical drivers-rising prevalence of cardiovascular and orthopedic disorders, heightened demand for outpatient procedures, and shifting demographics. This section delineates the pivotal shifts that are redrawing the fixed C-arm landscape and prescribing new benchmarks for performance and patient-centric care.

Assessing the Cumulative Impact of United States Tariffs Enacted in 2025 on Fixed C-arm Supply Chains and Competitive Dynamics Across Markets

In 2025, the United States enacted a series of tariff measures impacting key components integral to fixed C-arm manufacturing and distribution. These levies have introduced new cost variables at each stage of the supply chain, compelling manufacturers, distributors, and healthcare providers to reassess sourcing strategies. Suppliers of flat panel detectors, image intensifiers, and specialized X-ray tubes now face elevated duties, which have translated into incremental pricing pressures on end-user equipment.

Consequently, original equipment manufacturers have pursued dual pathways to mitigate these impacts: diversifying procurement origins and negotiating long-term agreements with tariff-exempt suppliers. Many have established regional distribution agreements to localize inventory and reduce transport-related expenses. In some cases, assembly operations have shifted closer to demand centers, thereby diminishing lead times and cushioning the effects of additional import costs.

Meanwhile, healthcare administrators are confronting the challenge of balancing budget constraints with the imperative to maintain cutting-edge imaging capabilities. Some institutions have adopted creative financing models, such as equipment-as-a-service contracts, to spread capital expenditures over multi-year horizons. Others have prioritized standardization across multiple sites to leverage volume-based discounts and reduce per-unit acquisition costs.

Despite these headwinds, the competitive dynamics have intensified. Manufacturers that can demonstrate robust value-through bundled service plans, extended warranties, and modular upgrade pathways-are cementing their positions. The cumulative impact of the 2025 tariff environment is thus reshaping pricing strategies, prompting innovative supply chain configurations, and reinforcing the necessity of strategic flexibility across the fixed C-arm ecosystem.

Deriving Strategic Insights from Comprehensive Fixed C-arm Market Segmentation Encompassing Technology End User Product Type and Clinical Applications

A nuanced segmentation analysis reveals distinct adoption patterns across technology tiers, end-user environments, product types, and application domains. By categorizing systems into two-dimensional and three-dimensional modalities, stakeholders can pinpoint where investments are directed and anticipate the maturation curve of advanced imaging suites. End users ranging from ambulatory surgical centers to diagnostic centers, hospitals, and specialty clinics exhibit varied purchasing criteria influenced by procedural volume, clinical specialization, and space constraints.

Likewise, the distinction between flat panel detector systems and image intensifier models informs discussions around image resolution, maintenance requirements, and total cost of ownership. Flat panel configurations generally deliver superior image uniformity and digital workflow integration, whereas legacy imagers may offer cost advantages for lower-acuity settings. Application segmentation, covering cardiovascular imaging, gastroenterology, orthopedic surgery, pain management, and urology, underscores how procedure-specific demands drive feature prioritization-whether it is low-dose fluoroscopy for pain interventions or high-contrast imaging for vascular mapping.

By weaving together these dimensions, decision-makers can isolate high-growth opportunities, tailor value propositions, and calibrate product roadmaps. The interplay between technology sophistication and clinical utility shapes not only purchasing decisions but also long-term upgrade strategies. Ultimately, this holistic segmentation perspective equips leadership teams with the clarity needed to address differentiated requirements across the full spectrum of fixed C-arm implementations.

Illuminating Regional Dynamics Driving Fixed C-arm Adoption Across Americas Europe Middle East Africa and Asia Pacific Market Trends and Clinical Demands

Regional dynamics exert a profound influence on both demand patterns and strategic priorities within the fixed C-arm domain. In the Americas, established healthcare systems are prioritizing the replacement of aging fleets and the adoption of three-dimensional imaging to support minimally invasive cardiac and orthopedic procedures. Budget cycles and reimbursement incentives further catalyze procurement, while domestic manufacturing capabilities offer resilience against tariff volatility.

Within Europe, Middle East, and Africa, regulatory harmonization efforts and cost-containment pressures are driving a balanced appetite for both premium and legacy imaging solutions. Governments and payers are increasingly focused on lifecycle cost analyses, compelling vendors to demonstrate the total economic impact of technology investments. In parallel, rising patient volumes in specialty clinics are generating demand for compact fixed C-arm platforms tailored to targeted interventions.

Across the Asia-Pacific region, rapid infrastructure expansion, burgeoning private healthcare networks, and a growing middle class are fueling remarkable growth in fixed C-arm adoption. Collaborative ventures between international suppliers and regional partners are accelerating technology transfer, enabling localized assembly and after-sales support. Additionally, emerging markets are leapfrogging to advanced digital systems to meet rising expectations for procedural efficiency and outcome predictability.

By dissecting these regional vectors, stakeholders can deploy differentiated go-to-market strategies, optimize channel partnerships, and anticipate future investment hotspots. A comprehensive appreciation of local regulatory environments, reimbursement frameworks, and clinical practice norms is essential for steering product development and commercial initiatives in each geography.

Profiling Leading Fixed C-arm Vendors Shaping Market Through Innovation Strategic Partnerships and Competitive Differentiation in a Dynamic Healthcare Setting

Leading vendors in the fixed C-arm space are distinguishing themselves through a combination of innovative hardware design, software-driven functionality, and holistic service offerings. Some have introduced modular upgrade kits that allow customers to transition from two-dimensional to three-dimensional imaging without full system replacement, thereby safeguarding capital investments. Others have leveraged cloud-based platforms for remote monitoring, predictive maintenance alerts, and software updates, effectively reducing downtime and optimizing asset utilization.

Strategic partnerships have also emerged as critical differentiators. Collaborations with robotics firms and digital health providers are enabling integrated procedure rooms that streamline workflows and enhance data integration across surgical environments. Meanwhile, selective joint ventures with regional distributors are strengthening market access in underserved territories, ensuring that comprehensive training and technical support accompany every deployment.

Competition is further defined by service excellence. Companies offering customizable service-level agreements-encompassing preventative maintenance schedules, rapid-response technical assistance, and outcomes-oriented training modules-are gaining recognition for minimizing operational disruption and maximizing clinician confidence. In turn, purchasing entities are assessing vendor credibility on a broader set of criteria that extends beyond equipment specifications to include total solution reliability.

Through this lens of vendor profiling, stakeholders can identify best-in-class strategies, benchmark performance metrics, and cultivate the partnerships necessary to sustain technological leadership in an increasingly competitive environment.

Empowering Industry Leaders with Actionable Recommendations to Accelerate Fixed C-arm Innovation Enhance Operational Efficiency and Foster Sustainable Growth

Industry leaders should begin by prioritizing research and development in three-dimensional imaging capabilities that reduce radiation exposure and enhance procedural precision. Investing in AI-driven image analytics will further elevate diagnostic confidence and support real-time decision-making. In tandem, cultivating partnerships with IT and robotic surgery providers can yield integrated solutions that align with evolving care models centered on minimally invasive therapies.

Operational resilience demands a proactive supply chain strategy. Leaders ought to diversify sourcing across tariff-exempt geographies, establish regional assembly or stocking hubs, and negotiate multi-year agreements to lock in favorable terms. Embracing equipment-as-a-service financing models can alleviate budget cycle constraints and foster closer collaboration between vendors and healthcare facilities on performance outcomes.

To address heterogeneous regional needs, companies should segment their commercial approach, aligning value propositions with distinct reimbursement frameworks and regulatory mandates. Tailored training programs and modular service offerings will cultivate end-user loyalty and accelerate adoption, particularly in emerging markets where clinical workflows may differ significantly.

Ultimately, the convergence of hardware innovation, service excellence, and strategic collaboration constitutes the blueprint for sustainable growth. By executing these recommendations, industry leaders can secure a competitive edge, drive meaningful improvements in patient care, and steer the future of fixed C-arm technology.

Detailing the Rigorous Research Methodology Underpinning Fixed C-arm Market Analysis Including Data Collection Validation and Analytical Frameworks

This analysis is grounded in a rigorous, multi-phase research methodology designed to ensure both breadth and depth of insight. Primary research encompassed in-depth interviews with a cross-section of key opinion leaders, including interventional radiologists, orthopedic surgeons, imaging technologists, and procurement executives. These conversations yielded qualitative perspectives on clinical needs, technology adoption drivers, and procurement decision processes.

In parallel, an exhaustive review of secondary sources was conducted, drawing upon peer-reviewed journals, regulatory filings, procedure volume databases, and vendor documentation. Data triangulation techniques were employed to validate findings, reconcile discrepancies, and enhance the robustness of the conclusions. Structured validation workshops brought together subject matter experts to challenge assumptions, refine analytical frameworks, and ensure alignment with real-world practice.

Quantitative analyses incorporated time-series data on procedure mix and technology utilization rates, enabling a nuanced understanding of both historic trends and emerging inflection points. Scenario modeling assessed the potential impacts of external variables such as tariff adjustments, reimbursement changes, and macroeconomic shifts. This structured approach facilitated the development of targeted segmentation insights, regional assessments, and strategic recommendations.

Together, these methodological building blocks underpin a cohesive narrative that marries empirical rigor with practical relevance, equipping stakeholders with actionable intelligence to navigate the fixed C-arm landscape with confidence.

Synthesizing Key Findings and Strategic Insights to Illuminate the Future Trajectory of Fixed C-arm Adoption Innovation and Value Delivery in Healthcare Systems

Throughout this executive summary, we have traversed the critical terrain shaping the trajectory of fixed C-arm technologies. From foundational introductions to the seismic shifts in clinical and regulatory landscapes, each section has contributed to a comprehensive understanding of how advanced imaging modalities are redefining patient care. The interplay of tariff dynamics, segmentation nuances, regional variations, and vendor strategies highlights the multifaceted nature of this market.

Key findings underscore the necessity for manufacturers and providers to remain adaptable: investing in next-generation imaging capabilities, reengineering supply chains for resilience, and aligning commercial approaches with diverse end-user requirements. The emergence of integrated procedure solutions and AI-driven analytics represents a paradigm shift that will accelerate minimally invasive therapies and enhance diagnostic precision.

Looking forward, stakeholders who leverage these insights will be well positioned to capitalize on growth opportunities while proactively addressing constraints. Whether through strategic partnerships, modular upgrade pathways, or tailored financing mechanisms, the capacity to deliver sustainable value will distinguish market leaders from laggards.

In closing, the fixed C-arm domain stands at an inflection point defined by technological convergence and evolving care models. Those who embrace innovation, operational agility, and patient-centric strategies will chart the course for future success and drive meaningful improvements across healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Surge in adoption of portable fixed C-arm systems enabling bedside imaging in critical care units
  • 5.2. Integration of artificial intelligence algorithms in fixed C-arm devices for automated image reconstruction
  • 5.3. Growing preference for flat-panel detector technology in fixed C-arm systems to enhance image clarity
  • 5.4. Rising implementation of 3D imaging capabilities in fixed C-arm units for complex orthopedic and spinal procedures
  • 5.5. Increasing demand for dose reduction features in fixed C-arm equipment driven by patient safety concerns
  • 5.6. Shift towards modular and mobile fixed C-arm architectures to optimize operating room workflows

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Fixed C-arm Market, by Product Type

  • 8.1. Introduction
  • 8.2. Angiographic C-arms
  • 8.3. Ceiling-Mounted C-arms
  • 8.4. Floor-Mounted C-arms

9. Fixed C-arm Market, by Technology

  • 9.1. Introduction
  • 9.2. Analog C-arm
  • 9.3. Digital C-arm

10. Fixed C-arm Market, by Detector Type

  • 10.1. Introduction
  • 10.2. Flat Panel Detectors
  • 10.3. Image Intensifier

11. Fixed C-arm Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiovascular Imaging
  • 11.3. Gastroenterology
  • 11.4. Oncology
  • 11.5. Orthopedic Surgery
  • 11.6. Urology

12. Fixed C-arm Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Diagnostic Centers
  • 12.4. Hospitals

13. Americas Fixed C-arm Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Fixed C-arm Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Fixed C-arm Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. BMI Biomedical International s.r.l.
    • 16.3.2. Canon Medical Systems Corporation
    • 16.3.3. Eurocolumbus srl.
    • 16.3.4. FUJIFILM Corporation
    • 16.3.5. GE HealthCare Technologies Inc
    • 16.3.6. Genoray Co., Ltd
    • 16.3.7. Hologic, Inc.
    • 16.3.8. Koninklijke Philips N.V
    • 16.3.9. MIZAR HEALTH, S.L
    • 16.3.10. MS Westfalia GmbH
    • 16.3.11. Nanjing Perlove Medical Equipment Co., Ltd.
    • 16.3.12. Shimadzu Corporation
    • 16.3.13. Siemens Healthineers
    • 16.3.14. Villa Sistemi Medicali Spa.
    • 16.3.15. Ziehm Imaging GmbH

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦